FDA Regulations and Recent Changes In early 2025, the FDA announced that the shortages of semaglutide and tirzepatide had officially ended
Together, these ingredients provide antioxidant protection, improve energy production, strengthen immunity, support cardiovascular and reproductive health, and promote overall vitality and wellness
It helps steady blood sugar and tells your brain you're full
In the published Phase 2 research (Jastreboff et al., NEJM 2023), Retatrutide produced the largest body-weight outcomes of any single-compound incretin programme reported to date, distinguishing the triple-agonist class from dual agonists like Tirzepatide and single-target agonists like Semaglutide
Patients with certain variants may experience faster receptor downregulation and earlier plateaus, while others maintain sensitivity longer